《Cancer Research And Treatment》雜志的最新年發文量為126篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在腫瘤學領域的學術影響力。
該刊聚焦于醫學-腫瘤學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 12周，或約稿 。
Cancer Research And Treatment 雜志發文統計
文章名稱引用次數
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 201594
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 201690
- The Generation and Application of Patient-Derived Xenograft Model for Cancer Research36
- Long Noncoding RNA HEIH Promotes Colorectal Cancer Tumorigenesis via Counteracting miR-939-Mediated Transcriptional Repression of Bcl-xL33
- Ferroptosis: A Novel Anti-tumor Action for Cisplatin33
- Prediction of Cancer Incidence and Mortality in Korea, 201929
- Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN29
- Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus-Positive and -Negative Relapsed or Refractory Non-Hodgkin Lymphomas18
- Prediction of Cancer Incidence and Mortality in Korea, 201816
- Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients15
國家/地區發文量
- South Korea310
- CHINA MAINLAND90
- USA26
- Japan8
- Taiwan8
- Italy5
- Spain4
- Australia3
- Canada3
- France3
